Stemtech Stock Profit Margin
| STEK Stock | USD 0.05 0 2.80% |
Stemtech fundamentals help investors to digest information that contributes to Stemtech's financial success or failures. It also enables traders to predict the movement of Stemtech OTC Stock. The fundamental analysis module provides a way to measure Stemtech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Stemtech otc stock.
Stemtech |
Stemtech OTC Stock Profit Margin Analysis
Stemtech's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Stemtech Profit Margin | (1.85) % |
Most of Stemtech's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Stemtech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Stemtech has a Profit Margin of -1.85%. This is 83.5% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The profit margin for all United States stocks is 45.67% higher than that of the company.
Did you try this?
Run Portfolio Manager Now
Portfolio ManagerState of the art Portfolio Manager to monitor and improve performance of your invested capital |
| All Next | Launch Module |
Stemtech Fundamentals
| Return On Asset | -0.75 | |||
| Profit Margin | (1.85) % | |||
| Operating Margin | (1.34) % | |||
| Current Valuation | 8.79 M | |||
| Shares Outstanding | 48.63 M | |||
| Shares Owned By Insiders | 63.60 % | |||
| Price To Sales | 1.54 X | |||
| Revenue | 4.32 M | |||
| Gross Profit | 3.3 M | |||
| EBITDA | 1.58 M | |||
| Net Income | (7.08 M) | |||
| Cash And Equivalents | 399.73 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 219.47 K | |||
| Current Ratio | 0.03 X | |||
| Book Value Per Share | (0.08) X | |||
| Cash Flow From Operations | (1.91 M) | |||
| Earnings Per Share | 0.10 X | |||
| Market Capitalization | 6.52 M | |||
| Total Asset | 5.72 M | |||
| Z Score | 17.4 | |||
| Net Asset | 5.72 M |
About Stemtech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Stemtech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Stemtech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Stemtech based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Stemtech OTC Stock
Stemtech financial ratios help investors to determine whether Stemtech OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Stemtech with respect to the benefits of owning Stemtech security.